跳至主要内容
临床试验/NCT02856074
NCT02856074已完成不适用

Prognosis After Revascularization Therapy in the Dijon Ischemic Stroke Evaluation Study

Centre Hospitalier Universitaire Dijon2 个研究点 分布在 1 个国家目标入组 821 人开始时间: 2016年1月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
821
试验地点
2
主要终点
Rate of handicap

研究概览

简要总结

The current management of ischemic stroke is based on different strategies that may be combined: intravenous thrombolysis in a stroke ICU, intravenous thrombolysis in a telemedicine procedure, endovascular thrombectomy. Given this now rich therapeutic arsenal, it seems necessary to evaluate practices in local care in the field and the impact of these on the prognosis of ischemic stroke victims. The aim of this observational study is to compare these different care practices without interfering with the choice of strategy.

A blood sample will also be taken at different times to study the value of growth differentiation factors (GDF) 8, 11 and 15, and Brain-derived Neurotrophic Factor as prognostic biomarkers

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with symptomatic ischemic stroke defined according to WHO criteria and treated by intravenous thrombolysis at the stroke ICU at Dijon CHU, intravenous thrombolysis by telemedicine with subsequent transfer to the Dijon stroke ICU, and/or endovascular thrombectomy at Dijon CHU)
  • Patients aged over 18 years.
  • Patients who have provided written informed consent to take part in the study.

排除标准

  • Patients who refuse to take part in the study.
  • Subjects in custody.
  • Patients (or a person of trust) who cannot be contacted by telephone during the follow-up.

结局指标

主要结局

Rate of handicap

时间窗: 6 months

次要结局

  • Serum levels of biomarkers of stress(Changes compared with baseline levels at Day 1, Day 3, Day 7)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Functional Prognosis in Patients With Ischemic... | 临床试验